Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

But making AbbVie an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of ABBV ...

The DuoBody platform has attracted multiple collaboration partners, including AbbVie Inc. (ABBV), Janssen, and Pfizer Inc.

Friday announced an agreement to acquire Nimble Therapeutics for a cash payment of $200 million at closing, along ...

The comorbidity burden of alopecia areata includes an increased risk for autoimmune and psychiatric conditions, like ...

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

AbbVie Inc (ABBV) stock saw a decline, ending the day at $173.19 which represents a decrease of $-1.18 or -0.68% from the prior close of $174.37. The stock opened at $174.91 and touched a low of $171.

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

The stock's fall snapped a two-day winning streak.

Astrocytes are star-shaped glial cells in the central nervous system that support neuronal function, maintain the blood-brain ...

AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $176.19 which represents a slight increase of $0.02 or 0.01% from the prior close of $176.17. The stock opened at $176 and touched a low ...